Cancer Genetics (CGIX) Appoints Thomas Widmann to its Board of Directors
Tweet Send to a Friend
Cancer Genetics, Inc. (Nasdaq: CGIX) today announced the appointment of renowned biotech entrepreneur Thomas F. Widmann, MD to the Company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
